US Tech 100

19,181.60

-0.43%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CLLS

Cellectis (CLLS)

Cellectis SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLLS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Date	Time	Source	Headline	Symbol	Company
04/29/2020	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
04/29/2020	4:30PM	GlobeNewswire Inc.	Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT	NASDAQ:CLLS	Cellectis SA
04/13/2020	4:45PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
04/13/2020	4:30PM	GlobeNewswire Inc.	Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer	NASDAQ:CLLS	Cellectis SA
03/10/2020	4:31PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
03/10/2020	4:30PM	Business Wire	US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis	NASDAQ:CLLS	Cellectis SA
03/10/2020	4:30PM	Business Wire	Cellectis obtient un brevet aux États-Unis couvrant les cellules CAR-T allogéniques ingénierées avec CRISPR-Cas9	NASDAQ:CLLS	Cellectis SA
03/06/2020	4:30PM	Business Wire	Cellectis : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social	NASDAQ:CLLS	Cellectis SA
03/06/2020	4:30PM	Business Wire	Cellectis: Monthly Information on Share Capital and Company Voting Rights	NASDAQ:CLLS	Cellectis SA
03/05/2020	6:06AM	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CLLS	Cellectis SA
03/04/2020	5:03PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
03/04/2020	4:30PM	Business Wire	Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results	NASDAQ:CLLS	Cellectis SA
03/04/2020	4:30PM	Business Wire	Cellectis publie ses résultats financiers du quatrième trimestre 2019 et de l’exercice 2019	NASDAQ:CLLS	Cellectis SA
03/04/2020	4:06PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
03/04/2020	4:05PM	Business Wire	Cellectis and Servier Execute the Amendment Confirming the Expansion of Their Collaboration on UCART19 Products	NASDAQ:CLLS	Cellectis SA
03/04/2020	4:05PM	Business Wire	Cellectis et Servier signent un avenant confirmant l’expansion de leur collaboration sur les produits UCART19	NASDAQ:CLLS	Cellectis SA
02/25/2020	4:31PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
02/25/2020	4:30PM	Business Wire	Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du quatrième trimestre 2019 et d...	NASDAQ:CLLS	Cellectis SA
02/25/2020	4:30PM	Business Wire	Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST	NASDAQ:CLLS	Cellectis SA
02/18/2020	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
02/18/2020	4:30PM	Business Wire	Cellectis et Servier étendent leur collaboration sur les produits UCART19	NASDAQ:CLLS	Cellectis SA
02/18/2020	4:30PM	Business Wire	Cellectis and Servier Expand Collaboration on UCART19 Products	NASDAQ:CLLS	Cellectis SA
02/14/2020	12:09PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CLLS	Cellectis SA
02/07/2020	11:17AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CLLS	Cellectis SA
01/15/2020	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
01/15/2020	4:30PM	Business Wire	Un premier patient a reçu une nouvelle version du produit candidat allogénique UCART123 de Cellectis pour traiter la leucé...	NASDAQ:CLLS	Cellectis SA
01/15/2020	4:30PM	Business Wire	First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia	NASDAQ:CLLS	Cellectis SA
01/13/2020	9:41AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CLLS	Cellectis SA
01/12/2020	4:00PM	GlobeNewswire Inc.	Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement	NASDAQ:CLLS	Cellectis SA
01/12/2020	4:00PM	Business Wire	Iovance Biotherapeutics et Cellectis ont signé un partenariat de recherche et un accord de licence mondiale exclusive	NASDAQ:CLLS	Cellectis SA